Zimmer Biomet (NYSE: ZBH)+
announced today that it received FDA 510(k) clearance for its G7 acetabular system for hip replacement surgeries.
YOUNGSTOWN, Ohio, Jan. 29, 2026 /PRNewswire/ — Nivalon Medical Technologies Inc. has successfully produced the world’s first fully patient-specific, motion-preserving spinal implant built entirely without metal, using AI-driven design and advanced ceramic 3D printing.
The FDA has authorised up to 15 clinical sites to take part in the study.
CORONADO, Calif., Jan. 26, 2026 /PRNewswire/ — Spine Innovation, LLC, a medical device startup that develops novel interbody fusion implants, announced today that is has received FDA 510(k) clearance to market the LOGIC™ Titanium Implant System.
The patent’s focus on a constant-slope transition ensures a gradual and predictable stiffness profile
Zimmer Biomet (NYSE: ZBH)+
recently announced the Brachiator mini-rail external fixation system.
SurGenTec’s ION-C system is now indicated for the treatment of cervical pseudoarthrosis when implanted bilaterally within the facet joints.
MORGANTOWN, W.Va., Jan. 20, 2026 /PRNewswire/ — Omnia Medical, a medical technology company developing surgical solutions for spine and interventional pain physicians, today announced the commercial launch of its FDA-cleared PsiF DNA™ Sacroiliac Joint Stabilization System.
SEATTLE, Jan. 15, 2026 /PRNewswire/ — Proprio, the surgical technology company pioneering real-time, AI-powered intraoperative guidance and data-driven surgical workflows, today announced the U.S. Food and Drug Administration (FDA) has granted clearance for the “Picasso” feature. This marks the company’s fourth FDA-cleared capability within its Paradigm platform.
Nanoparticles are engineered to home in on areas where cartilage has degenerated in osteoarthritis, ensuring that treatment concentrates exactly where it is needed